Shin Nippon Biomedical Laboratories, Ltd., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 60,954,626 shares at $0.91 ($55.5M) on 2023-06-08, disclosed to the SEC on 2023-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 22,053,581 | $20.1M | 36.2% |
| 2 | $0.91 | 22,053,581 | $20.1M | 36.2% |
| 3 | $0.91 | 8,423,732 | $7.7M | 13.8% |
| 4 | $0.91 | 8,423,732 | $7.7M | 13.8% |
| Total | $0.91 avg | 60,954,626 | $55.5M | 100% |